The anti-obesity and anti-diabetic effects of a highly specific \g=b\3-adrenoceptor agonist, CL316.243 
Introduction i83-adrenoceptors, which are different from known /3,-and ß^-adrenoceptors, and ß radrenoceptor mRNA are pre¬ sent in human white adipose tissue and brown adipose tissue (1, 2). The human ß j-adrenoceptor has recently been shown to be functionally active by in vitro and in vivo studies (3, 4). Furthermore, the Trp64Arg alíele of the ß adrenoreceptor is associated with abdominal obesity, insulin resistance syndrome, an earlier onset of noninsulin-dependent diabetes melitus (NIDDM), a lower resting metabolic rate and the difficulty of body weight loss in obese subjects (5) (6) (7) (8) . However, because ß}-adrenoceptor agonists (9) that stimulate lipolysis in white adipose tissue and activate brown adipose tissue could emerge as effective drugs for the treatment of obesity and diabetes in obese persons, the study and development of such substances are being actively pursued (10, 11) . In this study, the anti-obesity and anti-diabetic effects of a juVadrenoceptor agonist (CL316.243 (CL); ß^.ß,-.ß0
:1:100 000) (12) (13) (14) were investigated in Otsuka LongEvans Tokushima Fatty (OLETF; fatty) and Long-Evans Tokushima Otsuka (control) rats (15, 16) . The character¬ istic features of the fatty rats are (i) late onset of hyperglycemia (after 18 weeks of age), (ii) a chronic course of disease, (iii) mild obesity, and (iv) inheritance by males. These clinical and pathological features of disease in the fatty rats resemble those of human NLDDM. The control rats were obtained by different original matings from those for the fatty rats, but both strains originated from the same colony of Long-Evans rats. (27) . (25) and cytochrome c oxidase activity (26) . Uncoupling protein and GLUT4 protein in the fat-free extract was measured by Western blot analysis as described previously (29) . Briefly, the fat-free extracts (10 µg protein of brown adipose tissue and muscle, 20 µg of white adipose tissue) were solubilized, subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred to a nitrocellulose filter. After blocking with 5% non-fat dry milk, the filter was incubated with a rabbit antiserum against rat uncou¬ pling protein or GLUT4. The rabbit antisera against rat uncoupling protein and GLUT4 were prepared by immunizing purified rat uncoupling protein (30) and a 12-amino acid peptide corresponding to GLUT4 (31) respectively, coupled with keyhole limpet hemocyanin.
Materials and methods
Then the filter was incubated with [12,I] protein A (ICN).
The dry blot was exposed to an X-ray film for 926-2 ± 260-5at (1,20) [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] (1,36) (1,20) (1,20) (1.12) (1.12) (Fig. 4) . These parameters were increased by CL treatment in white adipose tissue of both the fatty and the control rats. However, the amounts of GLUT4 mRNA and its protein in muscle were not affected by CL treatment (Figs 3 and 4) .
Macroscopically, brown adipose tissue pads of CLtreated rats appeared dark brown, while brown adipose tissue pads of the distilled water-treated control rats were whitish brown. Fat 
Experiment 2
As shown in Fig. 6 , the levels of blood glucose and serum insulin were significantly higher in the fatty rats treated with distilled water for 14 weeks than those in the control rats treated with distilled water. Treatment with CL for 14 weeks decreased the blood glucose levels significantly in the fatty, but only slightly in the control rats. In addition, CL greatly reduced the serum insulin levels in the fatty rats.
Discussion
Dysfunction of brown adipose tissue has been shown to be one of the causes of obesity in various obesity models (34) (35) (36) The present findings that CL induced body weight loss and fat pad weight loss without affecting food intake and, furthermore, ameliorated hyperglycemia and hyperinsulinemia, were consistent with our own (13, 32, 33) and others (12, 14) previous findings.
This study showed that CL, a /^-adrenoceptor agonist, induced uncoupling protein (generally considered present only in brown adipose tissue (22, 23, 37) ) even in white adipose tissue. This is consistent with our previous study using yellow KK mice (32) , the report of Himms-Hagen et al. (14) showing that the mesenteric and intra-abdominal white fat depots contained numerous (29, 45) or by agonists including /33-agonists (21) . In this study, we found that /33-adrenoceptor agonists increased GLUT4 levels in brown and white adipose tissues, although there was no increase in the GLTJT4 level in muscle. Glucose uptake in skeletal muscle can be enhanced independently of the action of insulin (46) , probably through the mediation of 03-adrenoceptors present in the tissue. Therefore, the improvement in hyperglycemia and hyperinsulinemia observed in this obese model may be related to the increased number of insulin receptors associated with the decrease in fat pads, the increase in GLUT4 content in white and brown adipose tissues and, probably, the increase in glucose uptake in muscle.
Although it remains to be examined whether the present findings can be applied to humans, they cast a new light on the treatment of obesity using /33-adrenoceptor agonists.
